Pfizer Quality Improvement Request for Proposals: Improving the Vaccination Environment to Prevent Respiratory Infectious Diseases in Older Adults and High-Risk Individuals
Funds evidence-based projects in Japan to improve vaccination systems and access for older adults and high-risk groups, aiming to prevent respiratory infections like COVID-19, pneumococcal disease, and RSV.
Funder: Pfizer Inc.
Due Dates: September 15, 2026
Funding Amounts: Up to 7,500,000 JPY per project; project duration up to 2 years (possible extension to 3 years)
Summary: Supports quality improvement initiatives in Japan to optimize vaccination environments for older adults and high-risk individuals against respiratory infectious diseases.
Key Information: Only organizations (not individuals) may apply; projects must focus on system/environment improvements, not clinical research.
Description
This grant program funds quality improvement projects that aim to enhance the vaccination environment for older adults and high-risk individuals in Japan, with the goal of preventing respiratory infectious diseases such as COVID-19, pneumococcal disease, and RSV infection. The focus is on establishing systems that ensure smooth, reliable vaccination access, improving risk communication, and addressing barriers such as information access, consultation challenges, living environment constraints, and difficulties accessing vaccination sites. Projects should be evidence-based, may include educational or system-based components, and are expected to increase vaccination coverage and confidence in the target populations.
